# PREGNENOLONE: Clinical Guide for Practices

> Pregnenolone is a steroid hormone precursor synthesized from cholesterol, often called the 'mother hormone' because it serves as the starting point for the production of DHEA, progesterone, cortisol, testosterone, and estrogen. It is foundational in hormone replacement and anti-aging protocols, supporting the full steroidogenic cascade.

**FDA compounding category:** Available as supplement and compounded prescription; compounding eligibility varies by formulation  
**Category:** Hormonal Support  
**Route of administration:** Oral capsule, sublingual, topical cream

## Mechanism of action

Pregnenolone is synthesized from cholesterol via the enzyme CYP11A1 (P450scc) in mitochondria [3]. It serves as the universal precursor for all steroid hormones, converting to progesterone (via 3-beta-HSD), DHEA (via CYP17A1), and subsequently to cortisol, testosterone, and estradiol through downstream enzymatic pathways. As a neurosteroid, it also modulates GABA-A and NMDA receptors directly, supporting cognitive function independent of its hormonal conversion [2].

## Evidence summary

Clinical studies show that pregnenolone levels decline approximately 60% between ages 35 and 75 [3]. Supplementation studies demonstrate improved cognitive performance and mood in individuals with low baseline levels [1]. The neurosteroid literature supports direct CNS effects via GABA and NMDA receptor modulation [2]. Evidence for downstream hormonal optimization is primarily from clinical practice rather than large RCTs.

## Patient selection

Best candidates are patients with documented low serum pregnenolone, multiple downstream hormone deficiencies suggesting precursor insufficiency, or cognitive complaints concurrent with hormonal decline [1]. Patients with hormone-sensitive cancers, unpredictable steroid shunting toward cortisol under chronic stress, or those requiring precise hormonal control may be better served by targeted downstream hormone replacement [3].

## Clinical uses

- Hormone precursor support in HRT protocols (foundational steroid synthesis)
- Cognitive function and memory support (neurosteroid activity)
- Adrenal fatigue and stress response protocols
- Foundational hormone optimization before downstream hormone supplementation
- Joint and inflammatory support (via downstream metabolites)

## Protocols and dosing

Oral capsule (25-100mg daily) or sublingual/micronized formulations. Start at lower doses (10-25mg) and titrate based on serum levels and downstream hormone monitoring. Topical cream also available for transdermal delivery.

Begin at 10-25mg oral daily (micronized preferred for absorption) [1]. Recheck serum pregnenolone and downstream panel (progesterone, DHEA-S, cortisol, testosterone, estradiol) at 6-8 weeks. Titrate in 25mg increments, not exceeding 100mg daily without clear lab-based justification [3]. If conversion preferentially shunts to cortisol (elevated cortisol with minimal sex hormone improvement), consider adding targeted downstream hormones rather than increasing the pregnenolone dose further.

## Side effects to monitor

- Drowsiness or sedation (related to GABA-A receptor modulation at higher doses)
- Acne or oily skin if conversion favors androgenic pathways
- Mood changes (anxiety or agitation if cortisol conversion predominates)
- Headache (typically mild, more common during initial titration)

## Clinical considerations

Converts down multiple steroidogenic pathways; monitor downstream hormones (progesterone, DHEA, cortisol, testosterone, estradiol),May preferentially convert to cortisol or progesterone depending on individual HPA axis stress load,Start low and titrate based on labs to avoid unpredictable pathway shunting,Contraindicated in hormone-sensitive cancers (can feed androgen or estrogen pathways),Serum pregnenolone levels should be monitored to guide dosing

## Practice economics

Pregnenolone is an inexpensive foundational compound that anchors full HRT protocols [3]. While per-prescription revenue is modest, it strengthens patient relationships by demonstrating a systematic, upstream-first approach to hormone optimization. It drives downstream revenue when monitoring reveals the need for additional targeted interventions (progesterone, DHEA, testosterone) [1]. Practices offering full steroid panels and pregnenolone together create a differentiated, evidence-based service model.

## Frequently asked questions

### Why is pregnenolone called the 'mother hormone' and why does that matter clinically?

Pregnenolone sits at the top of the steroidogenic pathway, converting into progesterone, DHEA, cortisol, testosterone, and estrogen through various enzymatic steps. Supplementing pregnenolone supports the entire hormonal cascade, allowing the body to direct conversion based on need. This makes it a foundational intervention before adding specific downstream hormones, though the conversion is not always predictable.

### How do you determine whether a patient needs pregnenolone vs specific hormones?

Test pregnenolone levels alongside a full steroid hormone panel. Low pregnenolone with multiple downstream hormone deficiencies suggests a precursor deficit where pregnenolone supplementation may broadly improve the cascade. If pregnenolone is normal but specific downstream hormones are low, the issue is enzymatic conversion or end-organ, and targeted hormone replacement is more appropriate.

### What monitoring is needed for patients on pregnenolone?

Monitor serum pregnenolone, progesterone, DHEA-S, cortisol (AM), total and free testosterone, and estradiol at baseline and every 6-8 weeks during titration. Pay attention to which pathway predominates (cortisol vs sex hormones vs progesterone) as this guides whether to continue pregnenolone alone or add targeted downstream interventions.

## Sources

- [Marx et al. - Pregnenolone as a neurosteroid: cognitive and mood effects (2009)](https://pubmed.ncbi.nlm.nih.gov/19758531/)
- [Vallee et al. - Neurosteroids: deficient cognitive performance in aged rats depends on pregnenolone sulfate levels (1997)](https://pubmed.ncbi.nlm.nih.gov/9085061/)
- [Baulieu - Neurosteroids: a novel function of the brain (1998)](https://pubmed.ncbi.nlm.nih.gov/9504995/)

---

Canonical page: https://karpahealth.com/resources/peptides/pregnenolone/
Markdown version of the HTML page "pregnenolone" at that URL.
Machine-readable context: https://karpahealth.com/llms.txt · Pricing: https://karpahealth.com/pricing.md · Agents & API: https://karpahealth.com/agents.md